About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Terumo Shifts Focus from Oxymorphone Patch to Injectables
March 20, 2018
Click here to read more
Post navigation
Previous Post
Phosphagenics Placement Secures A$1.37 million
Next Post
Phosphagenics Newsletter – March 2018
Related Posts
Phosphagenics Still Awaits SIAC Arbitration Update
June 8, 2018
Phosphagenics Participation in ‘New Innovations in Drug Delivery Technology’ Webcast
April 12, 2017
Avecho licenses TPM® for development of enhanced cancer drugs
May 22, 2023
May 22, 2023